Onderstepoort Journal of Veterinary Research

1. Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge
Sandra Moreno, Eva Calvo-Pinilla, Stephanie Devignot, Friedemann Weber, Javier Ortego, Alejandro Brun, Michael R Holbrook
PLOS Neglected Tropical Diseases  vol: 14  issue: 12  first page: e0008942  year: 2020  
doi: 10.1371/journal.pntd.0008942

2. An Overview of Rift Valley Fever Vaccine Development Strategies
Paul Kato Kitandwe, Paul F. McKay, Pontiano Kaleebu, Robin J. Shattock
Vaccines  vol: 10  issue: 11  first page: 1794  year: 2022  
doi: 10.3390/vaccines10111794

3. Minimal Protective Antibody Titers Elicited in Sheep by RVFV MP-12 and arMP-12ΔNSm21/384 Vaccine Candidates
Watts Douglas M, Westover Jonna B, Palermo Pedro M, Monath Thomas P, Bailey Kevin W, Bettinger George E, Smith Darci R, Morrill John C, Pittman Phillip R, Orbegozo Jeanette, Gowen Brian B
International Journal of Veterinary Science and Research  vol: 10  issue: 3  first page: 046  year: 2024  
doi: 10.17352/ijvsr.000149

4. Rift Valley Fever – epidemiological update and risk of introduction into Europe
Søren Saxmose Nielsen, Julio Alvarez, Dominique Joseph Bicout, Paolo Calistri, Klaus Depner, Julian Ashley Drewe, Bruno Garin‐Bastuji, José Luis Gonzales Rojas, Christian Gortázar Schmidt, Virginie Michel, Miguel Ángel Miranda Chueca, Helen Clare Roberts, Liisa Helena Sihvonen, Karl Stahl, Antonio Velarde Calvo, Arvo Viltrop, Christoph Winckler, Bernard Bett, Catherine Cetre‐Sossah, Veronique Chevalier, Clazien Devos, Simon Gubbins, Federica Monaco, Antoniou Sotiria‐Eleni, Alessandro Broglia, José Cortiñas Abrahantes, Sofie Dhollander, Yves Van Der Stede, Gabriele Zancanaro
EFSA Journal  vol: 18  issue: 3  year: 2020  
doi: 10.2903/j.efsa.2020.6041

5. Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial
Daniel Jenkin, Daniel Wright, Pedro M Folegatti, Abigail Platt, Ian Poulton, Alison Lawrie, Nguyen Tran, Amy Boyd, Cheryl Turner, John N Gitonga, Henry K Karanja, Daisy Mugo, Katie J Ewer, Thomas A Bowden, Sarah C Gilbert, Bryan Charleston, Pontiano Kaleebu, Adrian V S Hill, George M Warimwe
The Lancet Infectious Diseases  vol: 23  issue: 8  first page: 956  year: 2023  
doi: 10.1016/S1473-3099(23)00068-3

6. Evaluation of a Combined Live Attenuated Vaccine against Lumpy Skin Disease, Contagious Bovine Pleuropneumonia and Rift Valley Fever
Zohra Bamouh, Amal Elarkam, Soufiane Elmejdoub, Jihane Hamdi, Zineb Boumart, Greg Smith, Matthew Suderman, Mahder Teffera, Hezron Wesonga, Stephen Wilson, Douglas M. Watts, Shawn Babiuk, Brad Pickering, Mehdi Elharrak
Vaccines  vol: 12  issue: 3  first page: 302  year: 2024  
doi: 10.3390/vaccines12030302

7. Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes
Corey L. Campbell, Trey K. Snell, Susi Bennett, John H. Wyckoff, Darragh Heaslip, Jordan Flatt, Emma K. Harris, Daniel A. Hartman, Elena Lian, Brian H. Bird, Mark D. Stenglein, Richard A. Bowen, Rebekah C. Kading
Transboundary and Emerging Diseases  vol: 69  issue: 5  first page: 2621  year: 2022  
doi: 10.1111/tbed.14415

8. Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice
J.C. Morrill, C.J. Peters, G.E. Bettinger, P.M. Palermo, D.R. Smith, D.M. Watts
Vaccine  vol: 40  issue: 50  first page: 7255  year: 2022  
doi: 10.1016/j.vaccine.2022.10.062

9. Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates
Cigdem Alkan, Eduardo Jurado-Cobena, Tetsuro Ikegami
npj Vaccines  vol: 8  issue: 1  year: 2023  
doi: 10.1038/s41541-023-00769-w

10. Increased Susceptibility of Cattle to Intranasal RVFV Infection
Andrea L. Kroeker, Valerie Smid, Carissa Embury-Hyatt, Brad Collignon, Mathieu Pinette, Shawn Babiuk, Bradley Pickering
Frontiers in Veterinary Science  vol: 7  year: 2020  
doi: 10.3389/fvets.2020.00137